This antagonist is a competitive inhibitor of the FSH receptor.rFSH-Ant can be produced using standard molecular biology and recombinant protein technologies.May be administered by a variety of routes, including intravenously, orally, locally and transdermally.
[更多]
Preferential delivery of protein cargo to the cytosol improves therapeutic efficacy of protein therapy. Packaged proteins are not covalently modified, thus preserving biological activity.
[更多]
Project ID: D2014-06Invention Description: Invention relates to a new olefin cross-metathesis approach for making C12 and C13 amino esters from oleic acid (or alkyl esters) originating from lipids. The method allows direct conversion of the widely abundant natural fatty acid oleic acid into syntheti.....
[更多]
Elimination of environmentally unfriendly and costly reductant chemicals
[更多]
Lead Inventors: Gordana Vunjak-Novakovic, Ph.D.; Yue ZhangProblem or Unmet Need:Tissue engineering a clinically useful patch of cardiac tissue to treat the massive loss of cardiomyocytes that typically occurs during myocardial infarctions requires a large number of cells in order to ensure functiona.....
[更多]
| |< <- | [3555] [3556] [3557] [3558] [3559] [3560] [3561] [3562] [3563] [3564] [3565] | -> >| |
